Literature DB >> 6271328

Toxic hepatis during ketoconazole treatment.

J K Heiberg, E Svejgaard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6271328      PMCID： PMC1507043          DOI： 10.1136/bmj.283.6295.825

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  An evaluation of two years of clinical experience with ketoconazole.

Authors:  J Symoens; M Moens; J Dom; H Scheijgrond; J Dony; V Schuermans; R Legendre; N Finestine
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

2.  Induction, modification and inhibition of rat liver microsomal benzo(a)pyrene hydroxylase; correlation with the S-9-mediated mutagenicity of benzo(a)pyrene.

Authors:  C Razzouk; E Agazzi-Léonard; J Cumps; F Poncelet; M Mercier; M Roberfroid
Journal:  Biochem Biophys Res Commun       Date:  1978-12-14       Impact factor: 3.575

3.  Treatment of chronic mucocutaneous candidosis with ketoconazole: a study of 12 cases.

Authors:  R J Hay; R S Wells; Y M Clayton; H J Wingfield
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

4.  Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin.

Authors:  M H Robertson; J M Hanifin; F Parker
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

5.  Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial.

Authors:  E A Petersen; D W Alling; C H Kirkpatrick
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391
  5 in total
  20 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  High-dose itraconazole in the treatment of severe mycoses.

Authors:  P K Sharkey; M G Rinaldi; J F Dunn; T C Hardin; R J Fetchick; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

3.  Prolonged jaundice following ketoconazole-induced hepatic injury.

Authors:  G D Benson; P K Anderson; B Combes; K G Ishak
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

Review 4.  Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.

Authors:  R Davis; J A Balfour
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

Review 5.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

6.  Ketoconazole.

Authors:  R Hay
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

7.  Ketoconazole: a reappraisal.

Authors:  R J Hay
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26

8.  Ketoconazole impairs biliary excretory function in the isolated perfused rat liver.

Authors:  G B Gaeta; M F Tripodi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

Review 9.  Antifungal agents used in systemic mycoses. Activity and therapeutic use.

Authors:  J R Graybill; P C Craven
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

10.  Melphalan, alone or conjugated to an FSH-β peptide, kills murine testicular cells in vitro and transiently suppresses murine spermatogenesis in vivo.

Authors:  John K Amory; SungWoo Hong; Xiaozhong Yu; Charles H Muller; Elaine Faustman; Alex Goldstein
Journal:  Theriogenology       Date:  2014-03-27       Impact factor: 2.740
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.